Epigenetic Clocks Reveal Disease-Driven Colon Ageing and Could Transform Gastroenterology Research

A new study has developed compact, colon-specific epigenetic clocks that accurately estimate the biological age of human colon tissue while revealing accelerated ageing associated with HIV infection, inflammatory bowel disease and colonic polyps.

Published in Scientific Reports, the research provides fresh evidence that disease may leave measurable molecular footprints on the ageing process of specific tissues. Rather than relying on hundreds of thousands of DNA methylation sites, researchers created a smaller model using tissue-specific CpG sites.

The resulting epigenetic clock showed a correlation of r=0.978 with chronological age and a mean absolute error of 3.9 years. More importantly, the same approach detected accelerated ageing signals in colon tissue affected by several disease processes.

For gastroenterologists and biomedical researchers, the findings could open a new avenue for investigating the relationship between chronic inflammation, infection, neoplasia and biological ageing.

What Is an Epigenetic Clock?

An epigenetic clock is a mathematical model that estimates biological age from molecular changes associated with ageing.

One of the most commonly studied signals is DNA methylation, a chemical modification that helps regulate gene activity without altering the DNA sequence itself.

As tissues age, methylation patterns at certain DNA locations can change in relatively predictable ways. Researchers can use these patterns to calculate an estimated biological age.

This differs from chronological age, which is simply the number of years a person has lived. Biological age attempts to capture aspects of how cells and tissues have changed over time.

The distinction is important because two people of identical chronological age may have tissues with very different biological characteristics.

Why the Colon Needs Its Own Biological Clock

Traditional epigenetic clocks have often been designed using very large numbers of DNA methylation sites. These models can provide valuable information, but their complexity can make them difficult to interpret and potentially demanding in terms of training data and molecular measurements.

The researchers took a more targeted approach by concentrating on tissue-unique CpG sites associated with the colon.

CpG sites are locations in DNA where cytosine is followed by guanine. Their methylation patterns can change with ageing and disease, making them useful targets for epigenetic research.

By focusing on markers that are particularly informative in colon tissue, the researchers sought to build a model that was both smaller and biologically relevant.

The Colon Epigenetic Clock Showed High Accuracy

The resulting model demonstrated a strong relationship between predicted tissue age and chronological age.

The reported correlation was r=0.978, while the mean absolute error was 3.9 years.

This means the model’s estimated age generally followed chronological age closely despite using far fewer molecular features than many conventional epigenetic-clock approaches.

The compact design is particularly noteworthy. If future studies confirm these results, smaller tissue-specific models could make biological-age research more efficient and easier to interpret.

The Model Captured Differences Across the Colon

The researchers also found that the clock reflected anatomical differences between the proximal and distal regions of the colon.

This matters because the colon is not biologically identical from one region to another. Different areas have distinct cellular environments and are exposed to different local conditions.

A model capable of detecting these regional differences could therefore provide a more precise picture of tissue ageing than a single age estimate for the entire organ.

This could become especially valuable in research into diseases that affect particular regions of the gastrointestinal tract.

Disease-Associated Colon Tissue Appeared to Age Faster

The researchers then applied the colon-specific clock to tissue from individuals affected by several conditions, including HIV infection, inflammatory bowel disease and colonic polyps.

Across these disease-associated tissues, the researchers observed consistent signals of accelerated ageing.

The finding suggests that disease-related changes in the colon may be reflected in its epigenetic ageing profile. Instead of tissue age simply tracking the passage of time, chronic biological stress may shift molecular characteristics toward an older state.

This is particularly interesting in inflammatory bowel disease, where prolonged inflammation can alter the intestinal environment and affect epithelial and immune processes.

However, the study demonstrates an association rather than proving that accelerated epigenetic ageing directly causes these diseases or determines their progression.

Inflammation May Be a Key Link Between Disease and Biological Age

One of the most important questions raised by the study is why disease-associated tissues appear biologically older.

Chronic inflammation is one possible explanation. Persistent inflammatory activity can alter cellular signalling, tissue repair and the local microenvironment. Over time, these processes may contribute to molecular changes that resemble or accompany ageing.

In the colon, this relationship may be especially important because the intestinal lining is constantly renewed and exposed to a complex biological environment.

Inflammation and ageing may therefore interact in both directions: ageing can influence how tissues respond to stress, while chronic inflammatory disease may accelerate certain features of biological ageing.

The new epigenetic clock provides researchers with a potential tool for investigating that relationship more precisely.

Colonic Polyps Add Another Important Dimension

The observation of accelerated ageing in tissue associated with colonic polyps is also significant.

Colonic polyps are growths arising from the lining of the colon. Some types can develop into colorectal cancer, making the biological changes surrounding polyp formation an important area of research.

The study does not establish that an accelerated epigenetic age predicts cancer or that the clock can identify which polyp will become malignant.

Nevertheless, the finding raises an important research question: could tissue-age measurements eventually help scientists understand why some areas of the colon become more vulnerable to abnormal growth?

That question will require prospective studies involving much larger patient populations and long-term clinical outcomes.

Aspirin Was Associated With Partial Deceleration

Another intriguing observation came from patients receiving aspirin treatment.

Aspirin exposure was associated with a partial deceleration of the ageing signal in the study.

This finding is potentially interesting because aspirin has been investigated extensively in relation to inflammation and colorectal neoplasia. However, the available study information does not establish that aspirin directly reverses biological ageing in colon tissue.

The analysis also did not provide enough information to determine how treatment duration, dose, patient characteristics or other clinical factors influenced the association.

Therefore, the aspirin finding should be regarded as a hypothesis-generating observation rather than evidence that aspirin should be used specifically to slow colon ageing.

Could a Colon Age Clock Eventually Become a Clinical Tool?

The study raises several possible clinical applications, but the technology is not yet ready to function as a routine diagnostic test.

A future colon-specific epigenetic clock could potentially be investigated as a way to:

• Measure biological ageing within colon tissue.
• Study the molecular effects of chronic inflammation.
• Track biological changes associated with gastrointestinal disease.
• Investigate tissue responses to treatment.
• Explore molecular differences associated with colorectal neoplasia.
• Identify biological pathways connecting ageing with intestinal disease.

However, each of these applications requires validation. Researchers would need to determine whether changes in predicted tissue age reliably correspond to symptoms, disease severity, treatment response or long-term outcomes.

Why Compact Epigenetic Clocks Could Be Valuable

The study’s emphasis on minimal features is more than a technical detail.

A model using fewer molecular markers can potentially be easier to analyse, reproduce and investigate biologically. Researchers may also be able to understand why particular CpG sites are informative rather than treating a massive collection of methylation markers as a black box.

This could help bridge the gap between machine learning and biological interpretation.

In medicine, prediction alone is rarely enough. Scientists also want to understand what the model is measuring and why that signal matters.

What the Study Does Not Prove

The findings are promising, but several limitations should be kept in mind.

• The study does not prove that accelerated epigenetic ageing causes disease.
• It does not establish that the clock can predict an individual’s future risk of colorectal cancer.
• It does not demonstrate that changing an epigenetic age score will improve patient outcomes.
• The aspirin association does not prove that aspirin slows biological ageing.
• The clock is not established as a routine clinical diagnostic tool.

These distinctions are important because biological-age research can easily be misunderstood as a direct measure of future health. An epigenetic age estimate is a molecular measurement, not a complete assessment of a patient’s overall health.

From Chronological Age to Tissue Age

The study represents a broader shift in biomedical research.

For decades, age was primarily treated as a number. Modern molecular research increasingly asks what age actually looks like inside individual tissues.

A person’s brain, liver, immune system and colon may not all age at precisely the same biological pace.

This concept of organ-specific ageing could eventually become important in understanding why diseases emerge in particular tissues and why individuals with similar chronological ages can experience very different health outcomes.

Why This Could Matter for Gastroenterology

Gastroenterology is particularly well suited to research involving tissue-level biological measurements because endoscopic procedures can provide direct access to gastrointestinal tissue for analysis.

If future research demonstrates that epigenetic age reliably changes with disease activity or treatment, colon-specific clocks could potentially become research biomarkers for studying disease mechanisms.

The most valuable application may not be simply telling a clinician that a patient’s colon is “older” than expected. Instead, it could help researchers understand which biological processes are driving that difference and whether those processes can be modified.

The Next Research Questions

The study opens several important avenues for future investigation.

• Does accelerated colon epigenetic ageing predict future disease progression?
• Can the clock distinguish active inflammation from previous inflammatory damage?
• Does successful treatment reverse or slow the ageing signal?
• Can the clock predict the development or recurrence of colorectal neoplasia?
• Do lifestyle factors influence colon-specific biological age?
• Can the model be validated across different populations and healthcare settings?
• Can the molecular measurement eventually be obtained from less invasive samples?

Answering these questions will determine whether the technology remains primarily a research tool or eventually becomes clinically useful.

Conclusion

A new colon-specific epigenetic clock has demonstrated that a relatively small number of tissue-specific DNA methylation sites can accurately estimate chronological age while also revealing biological ageing patterns associated with disease.

The model achieved a correlation of r=0.978 with chronological age and a mean absolute error of 3.9 years. More importantly, colon tissue associated with HIV infection, inflammatory bowel disease and colonic polyps showed signs of accelerated ageing.

The observation that aspirin treatment was associated with partial deceleration adds another intriguing research question, although it does not establish a treatment recommendation.

The larger significance of the study is its focus on tissue-specific biological age. If future studies confirm that these molecular clocks can track disease activity, treatment effects or future outcomes, they could provide researchers with a powerful way to study how chronic inflammation and neoplasia reshape the ageing colon.

For now, the technology should be viewed as a promising research tool rather than a clinical diagnostic test. But it points toward an increasingly sophisticated view of ageing—one in which doctors and scientists may eventually measure not only how old a patient is, but also how old a particular tissue appears to be biologically.